| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,152 | 15,546 | 15,496 | 15,809 | | Cost of Revenue | 3,316 | 3,404 | 3,255 | 3,546 | | | Gross Profit |
-
| 12,142 | 12,241 | 12,263 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,566 | 9,636 | 9,054 | 8,833 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | (16,500) | 3,300 | 1,908 | 819 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (794) | 1,279 | 2,611 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (4,030) | (794) | 1,279 | 2,611 | | Interest Expense | 457 | 480 | 539 | 624 | | Income Before Tax | (4,487) | (1,274) | 740 | 1,987 | | Income Tax Expense | (1,677) | (335) | 207 | 372 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,810) | (939) | 533 | 1,615 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,810) | (939) | 533 | 1,615 | | Preferred Stock And Other Adjustments | (263) | (263) | (259) |
-
| | | Net Income Applicable To Common Shares | ($3,073) | ($1,202) | $274 | $1,615 |
|
0.51% Nasdaq 
Income Statement
